Human equilibrative nucleoside transporter 1 and carcinoma of the ampulla of Vater: expression differences in tumour histotypes.
about
Nucleoside transporter proteins as biomarkers of drug responsiveness and drug targets.Identifying pathological biomarkers: histochemistry still ranks high in the omics era.On the future contents of a small journal of histochemistry.Prognostic effect of hENT1, dCK and HuR expression by morphological type in periampullary adenocarcinoma, including pancreatic cancer.Histochemistry through the years, browsing a long-established journal: novelties in traditional subjects.Human equilibrative nucleoside transporter 1 gene expression is associated with gemcitabine efficacy in advanced leiomyosarcoma and angiosarcoma.
P2860
Human equilibrative nucleoside transporter 1 and carcinoma of the ampulla of Vater: expression differences in tumour histotypes.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Human equilibrative nucleoside ...... ferences in tumour histotypes.
@ast
Human equilibrative nucleoside ...... ferences in tumour histotypes.
@en
type
label
Human equilibrative nucleoside ...... ferences in tumour histotypes.
@ast
Human equilibrative nucleoside ...... ferences in tumour histotypes.
@en
prefLabel
Human equilibrative nucleoside ...... ferences in tumour histotypes.
@ast
Human equilibrative nucleoside ...... ferences in tumour histotypes.
@en
P2093
P2860
P50
P356
P1476
Human equilibrative nucleoside ...... fferences in tumour histotypes
@en
P2093
P2860
P356
10.4081/EJH.2010.E38
P50
P577
2010-01-01T00:00:00Z